Innovotech (CVE:IOT) Sets New 1-Year High – Should You Buy?

Innovotech Inc. (CVE:IOTGet Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as C$0.21 and last traded at C$0.21, with a volume of 620 shares traded. The stock had previously closed at C$0.20.

Innovotech Price Performance

The stock has a fifty day moving average of C$0.18 and a two-hundred day moving average of C$0.15. The stock has a market capitalization of C$7.61 million, a price-to-earnings ratio of -19.50 and a beta of 1.15. The company has a current ratio of 2.63, a quick ratio of 5.81 and a debt-to-equity ratio of 12.55.

About Innovotech

(Get Free Report)

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection.

Read More

Receive News & Ratings for Innovotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovotech and related companies with MarketBeat.com's FREE daily email newsletter.